Open AccessLung Cancer: How Well We Have Fared?
Author(s) -
Pradeep S. Patil,
Hitendra S. Mahajan
Publication year - 2022
Publication title -
indo global journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
ISSN - 2249-1023
DOI - 10.35652/igjps.2022.12007
Subject(s) - medicine , lung cancer , intensive care medicine , death toll , disease , cancer , treatment of lung cancer , cause of death , oncology , environmental health
Lung Cancer has been one of the most common causes of death worldwide. With the death toll increasing in millions every year globally it has become a global scourge. With poor prognosis and disappointing 5 years survival rate post diagnosis, treatment for this disease has been ambiguous. Various advances in treatment are being made but till date the 5 years survival for major patients remains a dream. This review encompasses different treatment options that are available, problems associated with treatment and future perspective for the treatment of lung cancer. ©2022iGlobal Research and PublishingFoundation. All rights reserved.